Related Experiment Video
Updated: Aug 24, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Immune Checkpoint Blockade and Targeted Therapies in Esophageal Cancer
Jessica Yang1, Yelena Y Janjigian1
1Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 E66th Street, Room 1001, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College, 300 E66th Street, Room 1001, New York, NY 10065, USA.
Abstract:
Advanced esophageal cancer has one of the lowest 5-year survival rates. Historically, treatment options have been limited to cytotoxic chemotherapy but recent trials have established a key role for immune checkpoint inhibitors. Chemotherapy plus nivolumab or pembrolizumab now represents the new standard of care frontline regimen for both esophageal adenocarcinoma and squamous cell carcinoma. Advances in targeting HER2 and other molecular targets have also expanded our therapeutic landscape. This article aims to provide an overview of recent advances in immunotherapy and targeted therapy for esophageal cancer as well as summarize ongoing clinical trials and future directions.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
10:42Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
Published on: July 6, 2022
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Mitogens and the Cell Cycle
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...